Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain

Kaur, H.
May 2011
Internal Medicine Alert;5/29/2011 Supplement, p80
The article focuses on the double-blind crossover trial performed by H. Kaur and colleagues to compare the efficacy of amitriptyline with duloxetine in the treatment of diabetic peripheral neuropathic pain.


Related Articles

  • Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin. Enomoto, Hiroyuki; Yasuda, Hitoshi; Nishiyori, Atsushi; Fujikoshi, Shinji; Furukawa, Masashi; Ishida, Mitsuhiro; Takahashi, Masashi; Tsuji, Toshinaga; Yoshikawa, Aki; Alev, Levent // Journal of Pain Research;Sep2018, Vol. 11, p1857 

    Purpose: Duloxetine and pregabalin are recommended as first-line treatments for diabetic peripheral neuropathic pain (DPNP). However, studies have not reported a direct comparison between duloxetine and pregabalin. We conducted a postmarketing, randomized, double-blind study to assess the...

  • Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain. Kuritzky, Louis // Infectious Disease Alert;Jun2011 Clinical Briefs in Primary, p12 

    The article discusses research by H. Kaur and colleagues which compared the efficiency of amitriptyline and duloxetine for diabetic peripheral neuropathic pain, published in a 2011 issue of "Diabetes Care."

  • Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain.  // OB/GYN Clinical Alert;Jun2011 Clinical Brief, p12 

    The article discusses the double-blind crossover trial of amitriptyline and duloxetine in which these will be used as a treatment for diabetic peripheral neuropathic pain (DPNP).

  • Duloxetine.  // Reactions Weekly;8/8/2009, Issue 1264, p16 

    The article describes the case of a 61-year-old woman who developed hypomania while being treated with duloxetine. The patient had a history of recurrent depression and psychosis. She was treated with amitriptyline, mirtazapine, perphenazine, trifluoperazine and risperidone. She also was...

  • Controlling Diabetic Neuropathic Pain. Rubin, Michael // Internal Medicine Alert;11/29/2012, Vol. 34 Issue 22, p172 

    Three common medications -- amitripty-line, duloxetine, and pregabalin -- all appear equally efficacious in treating neuropathic pain from diabetic neuropathy.

  • Group Releases New Guideline on Options for Treating Painful Diabetic Neuropathy. Mitka, Mike // JAMA: Journal of the American Medical Association;6/22/2011, Vol. 305 Issue 24, p2507 

    The article focuses on the guideline released by the American Academy of Neurology in April 2011 for using effective therapies for patients with diabetic neuropathy. According to guideline author Vera Bril, the guideline was issued because of the availability of new treatments. It cites a study...

  • A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy. KAUR, HARJOT; HOTA, DEBASISH; BHANSALI, ANIL; DUTTA, PINAKI; BANSAL, DIPIKA; CHAKRABARTI, AMITAVA // Diabetes Care;Apr2011, Vol. 34 Issue 4, p818 

    OBJECTIVE--To compare the efficacy and safety of duloxetine and amitriptyline in painful diabetic neuropathy (PDN). RESEARCH DESIGN AND METHODS--In this randomized, double-blind, cross-over, active-control trial, 58 patients received amitriptyline and duloxetine orally once daily at bed-time,...

  • Diabetic neuropathy. Lipnick, Jesse A.; Lee, Thomas H. // American Family Physician;12/1/1996, Vol. 54 Issue 8, p2478 

    Discusses diabetic neuropathy, as a common cause of morbity in patients with diabetes. Five risk factors associated with the development of diabetic neuropathy; Differential diagnosis of diabetic neuropathy; Classification of diabetic neuropathy; Clinical syndromes of patient with diabetic...

  • Cost-effectiveness Analysis of Pharmacologic Treatment of Fibromyalgia in Mexico. Arreola Ornelas, Héctor; Rosado Buzzo, Alfonso; García, Lourdes; Dorantes Aguilar, Javier; Contreras Hernández, Iris; Mould Quevedod, Joaquín F. // Reumatologia Clinica;may/jun2012, Vol. 8 Issue 3, p120 

    Objective: To identify, from the Mexican Public Health System perspective, which would be the most cost-effective treatment for patients with fibromyalgia (FM). Material and methods: A Markov model including three health states, divided by pain intensity (absence or presence of mild, moderate or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics